Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Paoletti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Global & Regional Health Technology Assessment|May 12, 2025
Cost-effectiveness of cenobamate as a therapeutic alternative for the treatment of focal epilepsy in adults with inadequate seizure controlMartina Paoletti, Angela Ragonese, Luca Budassi, et al.
Clinical Drug Investigation|August 7, 2024
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in ItalyMartina Paoletti, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|April 18, 2023
Martina Paoletti, Andrea Marcellusi, Joe Yang, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Martina Paoletti, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Francesco Saverio Mennini, Andrea Marcellusi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 17, 2024
The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthmaMatteo Scortichini, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Francesco Saverio Mennini, Martina Paoletti, Chiara Bini, et al.
Global & Regional Health Technology Assessment|March 14, 2025
Assessing the economic burden of Waldenström's Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), and Chronic Lymphocytic Leukemia (CLL)Matteo Scortichini, Martina Paoletti, Angela Ragonese, et al.
Journal of Medical Economics|December 17, 2025
Transforming PAH care in Italy: a clinical and economic evaluation of sotatercept add-on therapyMartina Paoletti, Andrea Marcellusi, Danilo Di Laura, et al.
Drugs - Real World Outcomes|October 17, 2025
Economic and Social Burden of Pulmonary Arterial Hypertension in Italy: A Cost-of-Illness StudyMartina Paoletti, Dario Vizza, Michele D'Alto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Global & Regional Health Technology Assessment|May 12, 2025
Cost-effectiveness of cenobamate as a therapeutic alternative for the treatment of focal epilepsy in adults with inadequate seizure controlMartina Paoletti, Angela Ragonese, Luca Budassi, et al.
Clinical Drug Investigation|August 7, 2024
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in ItalyMartina Paoletti, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|April 18, 2023
Martina Paoletti, Andrea Marcellusi, Joe Yang, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Martina Paoletti, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Francesco Saverio Mennini, Andrea Marcellusi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 17, 2024
The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthmaMatteo Scortichini, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Francesco Saverio Mennini, Martina Paoletti, Chiara Bini, et al.
Global & Regional Health Technology Assessment|March 14, 2025
Assessing the economic burden of Waldenström's Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), and Chronic Lymphocytic Leukemia (CLL)Matteo Scortichini, Martina Paoletti, Angela Ragonese, et al.
Journal of Medical Economics|December 17, 2025
Transforming PAH care in Italy: a clinical and economic evaluation of sotatercept add-on therapyMartina Paoletti, Andrea Marcellusi, Danilo Di Laura, et al.
Drugs - Real World Outcomes|October 17, 2025
Economic and Social Burden of Pulmonary Arterial Hypertension in Italy: A Cost-of-Illness StudyMartina Paoletti, Dario Vizza, Michele D'Alto, et al.
Pageof 2